ASX:IHL Incannex Healthcare (IHL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Incannex Healthcare Stock (ASX:IHL) 30 days 90 days 365 days Advanced Chart Remove Ads Get Incannex Healthcare alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume627,285 shsAverage VolumeN/AMarket Capitalization$65.07 millionP/E RatioN/ADividend Yield16.80%Price TargetN/AConsensus RatingN/A Company OverviewIncannex Healthcare Limited, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. The company offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. It also develops IHL-42X, which has completed Phase IIb clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 skin that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury and concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, suppoCan gastro for IBD, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Docklands, Australia.Read More… Remove Ads Receive IHL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Incannex Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address IHL Stock News HeadlinesIncannex completes Phase 2 patient enrollment for RePOSA study of IHL-42XApril 4, 2025 | markets.businessinsider.comIncannex Healthcare Limited Reports Quarterly FinancialsFebruary 18, 2025 | tipranks.comElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. With Elon Musk leading the charge, supplies are vanishing fast. Don't wait until it's out of reach.April 8, 2025 | GoldenCrest Metals (Ad)Incannex reports Q2 EPS (33c) vs (33c) last yearFebruary 14, 2025 | markets.businessinsider.comIncannex appoints Alison Wimms to IHL-42X OSA Clinical Advisory BoardFebruary 4, 2025 | markets.businessinsider.comIncannex announces results from PK study of IHL-42XJanuary 24, 2025 | markets.businessinsider.comIncannex files to sell 61.39M shares of common stock for holdersNovember 8, 2024 | markets.businessinsider.comIncannex Healthcare: Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical OfficerOctober 24, 2024 | finanznachrichten.deSee More Headlines IHL Stock Analysis - Frequently Asked Questions How were Incannex Healthcare's earnings last quarter? Incannex Healthcare Limited (ASX:IHL) issued its earnings results on Wednesday, February, 27th. The company reported $0.00 earnings per share (EPS) for the quarter. Incannex Healthcare had a negative trailing twelve-month return on equity of 6.81% and a negative net margin of 1,129.38%. What other stocks do shareholders of Incannex Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Incannex Healthcare investors own include Tahoe Resources (TAHO), Pharmaxis (PXS), Metalicity (MCT), ECN Capital (ECN), 88 Energy (88E) and Hertz Global (HTZ). Company Calendar Last Earnings2/27/2019Today4/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:IHL CIKN/A Webimpression.healthcare Phone61 4 2570 3805FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($1.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,980,000.00 Net Margins-1,129.38% Pretax MarginN/A Return on Equity-6.81% Return on Assets-17.50% Debt Debt-to-Equity Ratio0.94 Current Ratio9.02 Quick Ratio18.80 Sales & Book Value Annual Sales$1.01 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.14 Book ValueA$0.05 per share Price / BookN/AMiscellaneous Outstanding Shares1,590,000,000Free FloatN/AMarket Cap$65.07 million OptionableNot Optionable Beta2.09 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (ASX:IHL) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt Discover why Notable Names ...Huge Alerts | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredWill the U.S. military protect this $10B gold mine?You don’t need the gold price to move another inch for this company to potentially re-rate several hundred per...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThese obscure companies are Trump’s favorites?Ten investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.